Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. D. Cardiff

Loss of Nrdp1 Enhances ErbB2/ErbB3-Dependent Breast Tumor Cell Growth

Cancer Research

Oncology

2006

English

How to Phenotype a Mouse

DMM Disease Models and Mechanisms

English

Related publications

ErbB3 Downregulation Enhances Luminal Breast Tumor Response to Antiestrogens

Journal of Clinical Investigation

Medicine

2013

English

An Insertion Mutation of ERBB2 Enhances Breast Cancer Cell Growth and Confers Resistance to Lapatinib Through AKT Signaling Pathway

English

Nuclear ErbB2 Enhances Translation and Cell Growth by Activating Transcription of Ribosomal RNA Genes

Cancer Research

Oncology

2011

English

ErbB3-Dependent Motility and Intravasation in Breast Cancer Metastasis

Cancer Research

Oncology

2006

English

Functional Isolation of Activated and Unilaterally Phosphorylated Heterodimers of ERBB2 and ERBB3 as Scaffolds in Ligand-Dependent Signaling

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2012

English

Oligomerization of the Nrdp1 E3 Ubiquitin Ligase Is Necessary for Efficient Autoubiquitination but Not ErbB3 Ubiquitination

Journal of Biological Chemistry

English

Nectin-Like Molecule-4/Cell Adhesion Molecule 4 Inhibits the Ligand-Induced Dimerization of ErbB3 With ErbB2

Scientific Reports

Multidisciplinary

2017

English

Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells

English

Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3

Molecular Cancer Therapeutics

Cancer Research

Oncology

2012

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. D. Cardiff

Loss of Nrdp1 Enhances ErbB2/ErbB3-Dependent Breast Tumor Cell Growth

How to Phenotype a Mouse

Related publications

ErbB3 Downregulation Enhances Luminal Breast Tumor Response to Antiestrogens

An Insertion Mutation of ERBB2 Enhances Breast Cancer Cell Growth and Confers Resistance to Lapatinib Through AKT Signaling Pathway

Nuclear ErbB2 Enhances Translation and Cell Growth by Activating Transcription of Ribosomal RNA Genes

ErbB3-Dependent Motility and Intravasation in Breast Cancer Metastasis

Functional Isolation of Activated and Unilaterally Phosphorylated Heterodimers of ERBB2 and ERBB3 as Scaffolds in Ligand-Dependent Signaling

Oligomerization of the Nrdp1 E3 Ubiquitin Ligase Is Necessary for Efficient Autoubiquitination but Not ErbB3 Ubiquitination

Nectin-Like Molecule-4/Cell Adhesion Molecule 4 Inhibits the Ligand-Induced Dimerization of ErbB3 With ErbB2

Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells

Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3